MICHAEL MALONE: Open Payments
NPI 1689693939 · PORTSMOUTH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 23 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $63 · 2025 $594
Food & beverage: $594
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $223 |
| Regeneron Healthcare Solutions, Inc. | 8 | $136 |
| GENZYME CORPORATION | 3 | $108 |
| Cochlear Americas | 1 | $63 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $20 |
Products named: DUPIXENT, NUCALA, COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE, NEFFY, TEZSPIRE, ImmunoCAP.
Industry payments across VA — which companies pay providers there.
